<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00059683</url>
  </required_header>
  <id_info>
    <org_study_id>U01HD039939-01A1</org_study_id>
    <nct_id>NCT00059683</nct_id>
  </id_info>
  <brief_title>Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women</brief_title>
  <official_title>Vaginal Ultrasound Cerclage Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregnant women who have a shortened cervix and have previously had a premature baby are at&#xD;
      increased risk for having another premature baby. This study will determine whether&#xD;
      reinforcing the cervix with a surgical stitch can reduce the chance of a premature birth.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women with a prior early spontaneous preterm birth and a shortened mid-trimester cervical&#xD;
      length (less than 25 mm) are at very high risk for having another premature baby. The Vaginal&#xD;
      Ultrasound Cerclage Trial is a multicenter, randomized clinical trial designed to determine&#xD;
      the efficacy of cerclage (a purse-string suture placed around the uterine cervix) for the&#xD;
      prevention of spontaneous preterm birth prior to 35 weeks' gestation. The study will evaluate&#xD;
      women at significant risk for recurrent spontaneous preterm birth (those with a prior&#xD;
      spontaneous birth at 17 to 32 weeks' gestation) and who have an increased risk based on&#xD;
      mid-trimester ultrasound findings of a cervical length less than 25 mm.&#xD;
&#xD;
      The trial will have an observational portion and an interventional portion. In the&#xD;
      observational portion, 1,000 women with a history of a spontaneous preterm birth at 17 to 32&#xD;
      weeks' gestation will undergo biweekly vaginal ultrasounds beginning at 16 to 18 weeks'&#xD;
      gestation and ending by 22 weeks. Prior research indicates that one third of these women will&#xD;
      either have or develop a cervix less than 25 mm long. Women will be seen at a frequency&#xD;
      determined by the cervical length (as determined by ultrasound examination starting at 16&#xD;
      weeks' gestation). If cervical length remains greater than 30 mm, the next visits will occur&#xD;
      in 2 week intervals until 22.6 weeks' gestation. If the cervical length is 25 mm to 29 mm,&#xD;
      the visits will be scheduled weekly. If the cervical length shortens to less than 25 mm, the&#xD;
      woman is eligible for randomization, and will undergo one more study visit.&#xD;
&#xD;
      In the interventional portion of the trial, women will be randomized to either cerclage or no&#xD;
      cerclage (control group). Randomized women will have weekly contact with a nurse either by&#xD;
      phone or in person, whichever is convenient for the woman, until delivery occurs. The woman&#xD;
      is followed during the course of her pregnancy and delivery of her infant. Her infant is&#xD;
      followed until discharge from the hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of preterm birth less than 35 weeks' gestation</measure>
    <time_frame>Birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational age at birth</measure>
    <time_frame>birth</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Labor, Premature</condition>
  <arm_group>
    <arm_group_label>Cervical Cerclage Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women randomized to receive cerclage should receive cervical cerclage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Women randomized to not receive cerclage represent the control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cervical cerclage</intervention_name>
    <description>Cerclage is a circumferential stitch of non-absorbable suture placed around the cervix</description>
    <arm_group_label>Cervical Cerclage Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Pregnant with a singleton gestation&#xD;
&#xD;
          -  History of at least 1 prior spontaneous preterm birth at or before 32 weeks' gestation&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Cervical cerclage planned for this pregnancy&#xD;
&#xD;
          -  Clinical history of cervical incompetence&#xD;
&#xD;
          -  Untreated C. trachomatis or N. gonorrhoeae infection or symptomatic vaginitis&#xD;
&#xD;
          -  Unable to obtain mid-trimester ultrasound to confirm no major fetal anomaly (i.e.,&#xD;
             aneuploidy, major organ system defect) or fetal demise prior to enrollment&#xD;
&#xD;
          -  Multiple gestation&#xD;
&#xD;
          -  Prolapsed or ruptured membranes noted on initial speculum examination&#xD;
&#xD;
          -  Cervical os dilation &gt; 2 cm noted on initial speculum examination&#xD;
&#xD;
          -  Oligohydramnios&#xD;
&#xD;
          -  Complete placenta previa&#xD;
&#xD;
          -  Chronic hypertension or vascular disease requiring therapy&#xD;
&#xD;
          -  Maternal red cell alloimmunization&#xD;
&#xD;
          -  Insulin dependent diabetes&#xD;
&#xD;
          -  Significant renal or cardiopulmonary disease&#xD;
&#xD;
          -  Delivery or prenatal care outside clinical center&#xD;
&#xD;
          -  Enrolled in this study in a previous pregnancy&#xD;
&#xD;
          -  Participation in a randomized trial with interventions or endpoints in conflict with&#xD;
             the cerclage randomized trial&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Owen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Owen J, Hankins G, Iams JD, Berghella V, Sheffield JS, Perez-Delboy A, Egerman RS, Wing DA, Tomlinson M, Silver R, Ramin SM, Guzman ER, Gordon M, How HY, Knudtson EJ, Szychowski JM, Cliver S, Hauth JC. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol. 2009 Oct;201(4):375.e1-8. doi: 10.1016/j.ajog.2009.08.015.</citation>
    <PMID>19788970</PMID>
  </results_reference>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>May 1, 2003</study_first_submitted>
  <study_first_submitted_qc>May 2, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2003</study_first_posted>
  <last_update_submitted>September 29, 2014</last_update_submitted>
  <last_update_submitted_qc>September 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</investigator_affiliation>
    <investigator_full_name>John Owen</investigator_full_name>
    <investigator_title>Professor Ob/Gyn-Maternal Fetal medicine</investigator_title>
  </responsible_party>
  <keyword>Preterm Birth</keyword>
  <keyword>Premature Birth</keyword>
  <keyword>Cervical cerclage</keyword>
  <keyword>Vaginal ultrasound</keyword>
  <keyword>Cervical length</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

